Vitamin B12 deficiency
|Vitamin B12 deficiency|
|Other names: Hypocobalaminemia, cobalamin deficiency|
|Symptoms||Decreased ability to think, depression, irritability, abnormal sensations, changes in reflexes|
|Causes||Poor absorption, decreased intake, increased requirements|
|Diagnostic method||Blood levels below 120–180 pmol/L (170–250 pg/mL) in adults|
|Prevention||Supplementation in those at high risk|
|Treatment||Supplementation by mouth or injection|
|Frequency||6% (<60 years old), 20% (>60 years old)|
Vitamin B12 deficiency, also known as cobalamin deficiency, is the medical condition of low blood and tissue levels of vitamin B12. In mild deficiency, a person may feel tired and have a reduced number of red blood cells (anemia). In moderate deficiency, soreness of the tongue may occur, and the beginning of neurological symptoms, including abnormal sensations such as pins and needles. Severe deficiency may include symptoms of reduced heart function as well as more severe neurological symptoms, including changes in reflexes, poor muscle function, memory problems, decreased taste, decrease level of consciousness, and psychosis. Infertility may occur. In young children, symptoms include poor growth, poor development, and difficulties with movement. Without early treatment, some of the changes may be permanent.
Causes are categorized as decreased absorption of vitamin B12 from the stomach or intestines, deficient intake, or increased requirements. Decreased absorption may be due to pernicious anemia, surgical removal of the stomach, chronic inflammation of the pancreas, intestinal parasites, certain medications, and some genetic disorders. Medications that may decrease absorption include proton pump inhibitors, H2-receptor blockers, and metformin. Decreased intake may occur in vegetarians and the malnourished. Increased requirements occur in people with HIV/AIDS, and in those with shortened red blood cell lifespan. Diagnosis is typically based on blood levels of vitamin B12 below 120–180 pmol/L (170 to 250 pg/mL) in adults. Elevated methylmalonic acid levels may also indicate a deficiency. A type of anemia known as megaloblastic anemia is often but not always present.
Treatment consists of using vitamin B12 by mouth or by injection; initially in high daily doses, followed by less frequent lower doses as the condition improves. If a reversible cause is found, that cause should be corrected if possible. If no reversible cause is found—or when found it cannot be eliminated—lifelong vitamin B12 administration is usually recommended. Vitamin B12 deficiency is preventable with supplements containing the vitamin: this is recommended in pregnant vegetarians and vegans, and not harmful in others. Risk of toxicity due to vitamin B12 is low.
Vitamin B12 deficiency in the US and the UK is estimated to occur in about 6 percent of those under the age of 60, and 20 percent of those over the age of 60. In Latin America, about 40 percent are estimated to be affected, and this may be as high as 80 percent in parts of Africa and Asia.
Signs and symptoms
Vitamin B12 deficiency can lead to anemia and neurological disorders. A mild deficiency may not cause any discernible symptoms, but as the deficiency becomes more significant, symptoms of anemia may result, such as weakness, fatigue, light-headedness, rapid heartbeat, rapid breathing and pale color to the skin. It may also cause easy bruising or bleeding, including bleeding gums, gastrointestinal side effects including sore tongue, stomach upset, weight loss, and diarrhea or constipation. If the deficiency is not corrected, nerve cell damage can result. If this happens, vitamin B12 deficiency may result in tingling or numbness to the fingers and toes, difficulty walking, mood changes, depression, memory loss, disorientation and, in severe cases, dementia. Tissue deficiency resulting in negative effects in nerve cells, bone marrow, and the skin.
- Anemia with bone marrow promegaloblastosis (megaloblastic anemia). This is due to the inhibition of DNA synthesis (specifically purines and thymidine)
- Gastrointestinal symptoms: alteration in bowel motility, such as mild diarrhea or constipation, and loss of bladder or bowel control. These are thought to be due to defective DNA synthesis inhibiting replication in a site with a high turnover of cells. This may also be due to the autoimmune attack on the parietal cells of the stomach in pernicious anemia. There is an association with GAVE syndrome (commonly called watermelon stomach) and pernicious anemia.
- Neurological symptoms: Sensory or motor deficiencies (absent reflexes, diminished vibration or soft touch sensation), subacute combined degeneration of spinal cord, or seizures. Deficiency symptoms in children include developmental delay, regression, irritability, involuntary movements and hypotonia.
The presence of peripheral sensory-motor symptoms or subacute combined degeneration of spinal cord strongly suggests the presence of a B12 deficiency instead of folate deficiency. Methylmalonic acid, if not properly handled by B12, remains in the myelin sheath, causing fragility. Dementia and depression have been associated with this deficiency as well, possibly from the under-production of methionine because of the inability to convert homocysteine into this product. Methionine is a necessary cofactor in the production of several neurotransmitters.
Each of those symptoms can occur either alone or along with others. The neurological complex, defined as myelosis funicularis, consists of the following symptoms:
- Impaired perception of deep touch, pressure and vibration, loss of sense of touch, very annoying and persistent paresthesias
- Ataxia of dorsal column type
- Decrease or loss of deep muscle-tendon reflexes
- Pathological reflexes – Babinski, Rossolimo and others, also severe paresis
Vitamin B12 deficiency can cause severe and irreversible damage, especially to the brain and nervous system. These symptoms of neuronal damage may not reverse after correction of blood abnormalities, and the chance of complete reversal decreases with the length of time the neurological symptoms have been present. Elderly people are at an even higher risk of this type of damage. In babies a number of neurological symptoms can be evident due to malnutrition or pernicious anemia in the mother. These include poor growth, apathy, having no desire for food, and developmental regression. While most symptoms resolve with supplementation some developmental and cognitive problems may persist.
Effect of folic acid
Large amounts of folic acid can correct the megaloblastic anemia caused by vitamin B12 deficiency without correcting the neurological abnormalities, and could also worsen the anemia and the cognitive symptoms associated with vitamin B12 deficiency. Due to the fact that in the United States legislation has required enriched flour to contain folic acid to reduce cases of fetal neural-tube defects, consumers may be ingesting more folate than they realize. To avoid this potential problem, the U.S. Food and Drug Administration recommends that folic acid intake from fortified food and supplements should not exceed 1,000 μg daily in healthy adults. The European Food Safety Authority reviewed the safety question and agreed with US that the UL be set at 1,000 μg. The Japan National Institute of Health and Nutrition set the adult UL at 1,300 or 1,400 μg depending on age.
Inadequate dietary intake of animal products such as eggs, meat, milk, fish, fowl (and some type of edible algae) can result in a deficiency state. Vegans, and to a lesser degree vegetarians, are at risk for B12 deficiency if they do not consume either a dietary supplement or vitamin-fortified foods. Children are at a higher risk for B12 deficiency due to inadequate dietary intake, as they have fewer vitamin stores and a relatively larger vitamin need per calorie of food intake.
- Selective impaired absorption of vitamin B12 due to intrinsic factor deficiency. This may be caused by the loss of gastric parietal cells in chronic atrophic gastritis (in which case, the resulting megaloblastic anemia takes the name of "pernicious anemia"), or may result from wide surgical resection of stomach (for any reason), or from rare hereditary causes of impaired synthesis of intrinsic factor. B12 deficiency is more common in the elderly because gastric intrinsic factor, necessary for absorption of the vitamin, is deficient, due to atrophic gastritis.
- Impaired absorption of vitamin B12 in the setting of a more generalized malabsorption or maldigestion syndrome. This includes any form due to structural damage or wide surgical resection of the terminal ileum (the principal site of vitamin B12 absorption).
- Forms of achlorhydria (including that artificially induced by drugs such as proton pump inhibitors and histamine 2 receptor antagonists) can cause B12 malabsorption from foods, since acid is needed to split B12 from food proteins and salivary binding proteins. This process is thought to be the most common cause of low B12 in the elderly, who often have some degree of achlorhydria without being formally low in intrinsic factor. This process does not affect absorption of small amounts of B12 in supplements such as multivitamins, since it is not bound to proteins, as is the B12 in foods.
- Surgical removal of the small bowel (for example in Crohn's disease) such that the patient presents with short bowel syndrome and is unable to absorb vitamin B12. This can be treated with regular injections of vitamin B12.
- Long-term use of ranitidine hydrochloride may contribute to deficiency of vitamin B12.
- Untreated celiac disease may also cause impaired absorption of this vitamin, probably due to damage to the small bowel mucosa. In some people, vitamin B12 deficiency may persist despite treatment with a gluten-free diet and require supplementation.
- Some bariatric surgical procedures, especially those that involve removal of part of the stomach, such as Roux-en-Y gastric bypass surgery. (Procedures such as the adjustable gastric band type do not appear to affect B12 metabolism significantly).
- Bacterial overgrowth within portions of the small intestine, such as may occur in blind loop syndrome, (a condition due to a loop forming in the intestine) may result in increased consumption of intestinal vitamin B12 by these bacteria.
- The diabetes medication metformin may interfere with B12 dietary absorption.
- A genetic disorder, transcobalamin II deficiency can be a cause.
- Nitrous oxide exposure, and recreational use.
- Infection with the Diphyllobothrium latum tapeworm
- Chronic exposure to toxigenic molds and mycotoxins found in water damaged buildings.
The total amount of vitamin B12 stored in the body is between two and five milligrams in adults. Approximately 50% is stored in the liver, but approximately 0.1% is lost each day, due to secretions into the gut—not all of the vitamin in the gut is reabsorbed. While bile is the main vehicle for B12 excretion, most of this is recycled via enterohepatic circulation. Due to the extreme efficiency of this mechanism, the liver can store three to five years worth of vitamin B12 under normal conditions and functioning. However, the rate at which B12 levels may change when dietary intake is low depends on the balance between several variables.
Vitamin B12 deficiency causes particular changes to the metabolism of two clinically relevant substances in humans:
- Homocysteine (homocysteine to methionine, catalysed by methionine synthase) leading to hyperhomocysteinemia
- Methylmalonic acid (methylmalonyl-CoA to succinyl-CoA, of which methylmalonyl-CoA is made from methylmalonic acid in a preceding reaction)
Methionine is activated to S-adenosyl methionine, which aids in purine and thymidine synthesis, myelin production, protein/neurotransmitters/fatty acid/phospholipid production and DNA methylation. 5-Methyl tetrahydrofolate provides a methyl group, which is released to the reaction with homocysteine, resulting in methionine. This reaction requires cobalamin as a cofactor. The creation of 5-methyl tetrahydrofolate is an irreversible reaction. If B12 is absent, the forward reaction of homocysteine to methionine does not occur, homocysteine concentrations increase, and the replenishment of tetrahydrofolate stops. Because B12 and folate are involved in the metabolism of homocysteine, hyperhomocysteinuria is a non-specific marker of deficiency. Methylmalonic acid is used as a more specific test of B12 deficiency.
Early changes include a spongiform state of neural tissue, along with edema of fibers and deficiency of tissue. The myelin decays, along with axial fiber. In later phases, fibric sclerosis of nervous tissues occurs. Those changes occur in dorsal parts of the spinal cord and to pyramidal tracts in lateral cords and is called subacute combined degeneration of spinal cord. Pathological changes can be noticed as well in the posterior roots of the cord and, to lesser extent, in peripheral nerves.
In the brain itself, changes are less severe: They occur as small sources of nervous fibers decay and accumulation of astrocytes, usually subcortically located, and also round hemorrhages with a torus of glial cells.
MRI of the brain may show periventricular white matter abnormalities. MRI of the spinal cord may show linear hyperintensity in the posterior portion of the cervical tract of the spinal cord, with selective involvement of the posterior columns.
The diagnosis is frequently first suspected when a routine complete blood count shows anemia with an elevated MCV. In addition, on the peripheral blood smear, macrocytes and hypersegmented polymorphonuclear leukocytes may be seen.
Diagnosis is typically confirmed based on vitamin B12 blood levels below 120–180 pmol/L (170–250 pg/mL) in adults. Elevated serum homocysteine (over 12 μmol/L) and methylmalonic acid (over 0.4 micromol/L) levels are considered more reliable indicators of B12 deficiency than the concentration of B12 in blood. If nervous system damage is present and blood testing is inconclusive, a lumbar puncture to measure cerebrospinal fluid B-12 levels may be done. On bone marrow aspiration or biopsy, megaloblasts are seen.
B12 can be supplemented by pill or injection and appears to be equally effective in those with low levels due to deficient absorption of B12. When large doses are given by mouth its absorption does not rely on the presence of intrinsic factor or an intact ileum. Instead, these large-dose supplements result in 1% to 5% absorption along the entire intestine by passive diffusion. Generally 1 to 2 mg daily is required as a large dose. Even pernicious anemia can be treated entirely by the oral route.
Vitamin B12 deficiency is common and occurs worldwide. In the US and UK, around 6 percent of the general population have the deficiency; in those over the age of sixty, around 20 percent are deficient. In under-developed countries, the rates are even higher: across Latin America 40 percent are deficient; in some parts of Africa, 70 percent; and in some parts of India, 70 to 80 percent.
Between 1849 and 1887, Thomas Addison described a case of pernicious anemia, William Osler and William Gardner first described a case of neuropathy, Hayem described large red cells in the peripheral blood in this condition, which he called "giant blood corpuscles" (now called macrocytes), Paul Ehrlich identified megaloblasts in the bone marrow, and Ludwig Lichtheim described a case of myelopathy. During the 1920s, George Whipple discovered that ingesting large amounts of liver seemed to most rapidly cure the anemia of blood loss in dogs, and hypothesized that eating liver might treat pernicious anemia. Edwin Cohn prepared a liver extract that was 50 to 100 times more potent in treating pernicious anemia than the natural liver products. William Castle demonstrated that gastric juice contained an "intrinsic factor" which when combined with meat ingestion resulted in absorption of the vitamin in this condition. In 1934, George Whipple shared the 1934 Nobel Prize in Physiology or Medicine with William P. Murphy and George Minot for discovery of an effective treatment for pernicious anemia using liver concentrate, later found to contain a large amount of vitamin B12.
In the early 20th century, during the development for farming of the North Island Volcanic Plateau of New Zealand, cattle suffered from what was termed "bush sickness". It was discovered in 1934 that the volcanic soils lacked the cobalt salts essential for synthesis of vitamin B12 by their gut bacteria. The "coast disease" of sheep in the coastal sand dunes of South Australia in the 1930s was found to originate in nutritional deficiencies of the trace elements, cobalt and copper. The cobalt deficiency was overcome by the development of "cobalt bullets", dense pellets of cobalt oxide mixed with clay given orally, which then was retained in the animal's rumen.
- Hunt, A; Harrington, D; Robinson, S (4 September 2014). "Vitamin B12 deficiency" (PDF). BMJ. 349. g5226. doi:10.1136/bmj.g5226. PMID 25189324. Archived from the original (PDF) on 12 March 2017. CS1 maint: discouraged parameter (link)
- "Dietary Supplement Fact Sheet: Vitamin B12 — Health Professional Fact Sheet". National Institutes of Health: Office of Dietary Supplements. 2016-02-11. Archived from the original on 2016-07-27. Retrieved 2016-07-15. CS1 maint: discouraged parameter (link)
- Wang, H; Li, L; Qin, LL; Song, Y; Vidal-Alaball, V; Liu, TH (March 2018). "Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency". Cochrane Database of Systematic Reviews. 3. CD004655. doi:10.1002/14651858.CD004655.pub3. PMC 5112015. PMID 29543316.
- Herrmann, Wolfgang (2011). Vitamins in the prevention of human diseases. Berlin: Walter de Gruyter. p. 245. ISBN 9783110214482.
- "Complications". nhs.uk. 2017-10-20.
- Lachner, C; Steinle, NI; Regenold, WT (2012). "The neuropsychiatry of vitamin B12 deficiency in elderly patients". The Journal of Neuropsychiatry and Clinical Neurosciences. 24 (1): 5–15. doi:10.1176/appi.neuropsych.11020052. PMID 22450609.
- Miller, JW (1 July 2018). "Proton Pump Inhibitors, H2-Receptor Antagonists, Metformin, and Vitamin B-12 Deficiency: Clinical Implications". Advances in Nutrition (Bethesda, Md.). 9 (4): 511S–518S. doi:10.1093/advances/nmy023. PMC 6054240. PMID 30032223.
- Pawlak, R; Parrott, SJ; Raj, S; Cullum-Dugan, D; Lucus, D (February 2013). "How prevalent is vitamin B(12) deficiency among vegetarians?". Nutrition Reviews. 71 (2): 110–17. doi:10.1111/nure.12001. PMID 23356638.
- Hankey, Graeme J.; Wardlaw, Joanna M. (2008). Clinical neurology. London: Manson. p. 466. ISBN 978-1840765182. CS1 maint: discouraged parameter (link)
- Schwartz, William (2012). The 5-minute pediatric consult (6th ed.). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. p. 535. ISBN 9781451116564.
- Reynolds, E.H. (2014). "The neurology of folic acid deficiency". In Biller, José; Ferro, José M. (eds.). Neurologic aspects of systemic disease. Handbook of Clinical Neurology. 120. pp. 927–43. doi:10.1016/B978-0-7020-4087-0.00061-9. ISBN 9780702040870. PMID 24365361.
- Briani C, Dalla Torre C, Citton V, Manara R, Pompanin S, Binotto G, Adami F (2013). "Cobalamin Deficiency: Clinical Picture and Radiological Findings". Nutrients. 5 (11): 4521–39. doi:10.3390/nu5114521. ISSN 2072-6643. PMC 3847746. PMID 24248213.
- Amarapurka DN, Patel ND (September 2004). "Gastric Antral Vascular Ectasia (GAVE) Syndrome" (PDF). Journal of the Association of Physicians of India. 52: 757. Archived (PDF) from the original on 2016-03-04. CS1 maint: discouraged parameter (link)
- Matsumoto A, Shiga Y, Shimizu H, Kimura I, Hisanaga K (Apr 2009). "[Encephalomyelopathy due to vitamin B12 deficiency with seizures as a predominant symptom]". Rinsho Shinkeigaku. 49 (4): 179–85. doi:10.5692/clinicalneurol.49.179. PMID 19462816.
- Kumar S (Mar 2004). "Recurrent seizures: an unusual manifestation of vitamin B12 deficiency". Neurology India. 52 (1): 122–23. PMID 15069260. Archived from the original on 2011-01-23. CS1 maint: discouraged parameter (link)
- Kliegman, Robert M.; Stanton, Bonita; St. Geme, Joseph; Schor, Nina F, eds. (2016). Nelson Textbook of Pediatrics (20th ed.). pp. 2319–26. ISBN 978-1-4557-7566-8.
- Stabler SP, Lindenbaum J, Allen RH (1997-10-01). "Vitamin B-12 deficiency in the elderly: current dilemmas". The American Journal of Clinical Nutrition. 66 (4): 741–49. doi:10.1093/ajcn/66.4.741. ISSN 0002-9165. PMID 9322547.
- Dror DK, Allen LH (May 2008). "Effect of vitamin B12 deficiency on neurodevelopment in infants: current knowledge and possible mechanisms". Nutrition Reviews. 66 (5): 250–55. doi:10.1111/j.1753-4887.2008.00031.x. PMID 18454811.
- Black MM (Jun 2008). "Effects of vitamin B12 and folate deficiency on brain development in children". Food and Nutrition Bulletin. 29 (2 Suppl): S126–31. doi:10.1177/15648265080292S117. PMC 3137939. PMID 18709887.
- Moore E, Mander A, Ames D, Carne R, Sanders K, Watters D (April 2012). "Cognitive impairment and vitamin B12: a review". International Psychogeriatrics. 24 (4): 541–56. doi:10.1017/S1041610211002511. PMID 22221769.
- Janos Zempleni; John W. Suttie; Jesse F. Gregory III; Patrick J. Stover, eds. (2014). Handbook of vitamins (Fifth ed.). Hoboken: CRC Press. p. 477. ISBN 9781466515574. Archived from the original on 2016-08-17. CS1 maint: discouraged parameter (link)
- Melinda Beck (January 18, 2011). "Sluggish? Confused? Vitamin B12 May Be Low". Wall Street Journal. Archived from the original on September 8, 2017. CS1 maint: discouraged parameter (link)
- Institute of Medicine (1998). "Folate". Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, DC: The National Academies Press. pp. 196–305. ISBN 978-0-309-06554-2. Retrieved 25 September 2019.
- "Tolerable Upper Intake Levels For Vitamins And Minerals" (PDF). European Food Safety Authority. 2006.
- Shibata K, Fukuwatari T, Imai E, Hayakawa T, Watanabe F, Takimoto H, Watanabe T, Umegaki K (2013). "Dietary Reference Intakes for Japanese 2010: Water-Soluble Vitamins". Journal of Nutritional Science and Vitaminology. 2013 (59): S67–S82.
- Croft MT, Lawrence AD, Raux-Deery E, Warren MJ, Smith AG (Nov 2005). "Algae acquire vitamin B12 through a symbiotic relationship with bacteria". Nature. 438 (7064): 90–93. Bibcode:2005Natur.438...90C. doi:10.1038/nature04056. PMID 16267554. S2CID 4328049.
- Rasmussen, SA; Fernhoff, PM; Scanlon, KS (January 2001). "Vitamin B12 deficiency in children and adolescents". The Journal of Pediatrics. 138 (1): 10–17. doi:10.1067/mpd.2001.112160. PMID 11148506.
- Baik HW, Russell RM (1999). "Vitamin B12 deficiency in the elderly". Annual Review of Nutrition. 19: 357–77. doi:10.1146/annurev.nutr.19.1.357. PMID 10448529.
- Lam JR, Schneider JL, Zhao W, Corley DA (Dec 2013). "Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency". JAMA: The Journal of the American Medical Association. 310 (22): 2435–42. doi:10.1001/jama.2013.280490. PMID 24327038.
- Yeomans ND, Hanson RG, Smallwood RA, Mihaly GW, Louis WJ (1982). "Effect of chronic ranitidine treatment on secretion of intrinsic factor". British Medical Journal (Clinical Research Ed.). 285 (6337): 264. doi:10.1136/bmj.285.6337.264. PMC 1499627. PMID 6124297.
- Caruso R, Pallone F, Stasi E, Romeo S, Monteleone G (2013). "Appropriate nutrient supplementation in celiac disease". Annals of Medicine (Review). 45 (8): 522–31. doi:10.3109/07853890.2013.849383. PMID 24195595. S2CID 11093737.
- "Blind loop syndrome - Diagnosis and treatment - Mayo Clinic". www.mayoclinic.org. Archived from the original on 2018-05-09. CS1 maint: discouraged parameter (link)
- Ting RZ, Szeto CC, Chan MH, Ma KK, Chow KM (Oct 2006). "Risk factors of vitamin B(12) deficiency in patients receiving metformin". Archives of Internal Medicine. 166 (18): 1975–79. doi:10.1001/archinte.166.18.1975. PMID 17030830.
- Nagao, T; Hirokawa, M (October 2017). "Diagnosis and treatment of macrocytic anemias in adults". Journal of General and Family Medicine. 18 (5): 200–04. doi:10.1002/jgf2.31. PMC 5689413. PMID 29264027.
- Kondo H, Osborne ML, Kolhouse JF, Binder MJ, Podell ER, Utley CS, Abrams RS, Allen RH (May 1981). "Nitrous oxide has multiple deleterious effects on cobalamin metabolism and causes decreases in activities of both mammalian cobalamin-dependent enzymes in rats". Journal of Clinical Investigation. 67 (5): 1270–83. doi:10.1172/JCI110155. PMC 370693. PMID 6112240.
- Anyanwu, EC; Morad, M; Campbell, AW (26 August 2004). "Metabolism of mycotoxins, intracellular functions of vitamin B12, and neurological manifestations in patients with chronic toxigenic mold exposures. A review". TheScientificWorldJournal. 4: 736–45. doi:10.1100/tsw.2004.133. PMC 5956359. PMID 15349513.
- Anyanwu, EC; Kanu, I (12 October 2007). "Biochemical impedance on intracellular functions of vitamin B12 in chronic toxigenic mold exposures". The Scientific World Journal. 7: 1649–57. doi:10.1100/tsw.2007.113. ISSN 1537-744X. PMC 5900526. PMID 17982599.
- Voet, Donald; Voet, Judith G. (2010). Biochemistry. New York: J. Wiley & Sons. p. 957. ISBN 978-0470-57095-1. Unknown parameter
- Yamada, Kazuhiro (2013). "Chapter 9. Cobalt: Its Role in Health and Disease". In Astrid Sigel, Helmut Sigel and Roland K. O. Sigel (ed.). Interrelations between Essential Metal Ions and Human Diseases. Metal Ions in Life Sciences. 13. Springer. pp. 295–320. doi:10.1007/978-94-007-7500-8_9. ISBN 978-94-007-7499-5. PMID 24470095. Unknown parameter
- Shane B, Stokstad EL (1985). "Vitamin B12-folate interrelationships". Annual Review of Nutrition. 5: 115–41. doi:10.1146/annurev.nu.05.070185.000555. PMID 3927946.
- "Vitamin B12 / Pathophysiology Text". LifeSave.org. p. 215. Archived from the original on 2013-02-06. Retrieved 2013-12-31. CS1 maint: discouraged parameter (link)
- "Test used to diagnose B12 deficiency may be inadequate". news-medical.net. October 28, 2004. Archived from the original on September 29, 2007. Retrieved 2007-12-04. CS1 maint: discouraged parameter (link)
- Devalia V (Aug 2006). "Diagnosing vitamin B-12 deficiency on the basis of serum B-12 assay". BMJ. 333 (7564): 385–86. doi:10.1136/bmj.333.7564.385. PMC 1550477. PMID 16916826.
- Nickoloff E (1988). "Schilling test: physiologic basis for and use as a diagnostic test". Crit Rev Clin Lab Sci. 26 (4): 263–76. doi:10.3109/10408368809105892. PMID 3077032.
- Lane, LA; Rojas-Fernandez, C (2002). "Treatment of vitamin b(12)-deficiency anemia: oral versus parenteral therapy". Annals of Pharmacotherapy. 36 (7–8): 1268–72. doi:10.1345/aph.1A122. PMID 12086562. S2CID 919401.
- Butler, CC; Vidal-Alaball, J; Cannings-John, R; McCaddon, A; Hood, K; Papaioannou, A; McDowell, I; Goringe, A (2006). "Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency: A systematic review of randomized controlled trials". Family Practice. 23 (3): 279–85. doi:10.1093/fampra/cml008. PMID 16585128.
- Greer, John P. (2014). Wintrobe's Clinical Hematology Thirteenth Edition. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins. ISBN 978-1-4511-7268-3. Unknown parameter
|name-list-format=ignored (help) Chapter 36: Megaloblastic anemias: disorders of impaired DNA synthesis by Ralph Carmel
- "George H. Whipple – Biographical". www.nobelprize.org. Retrieved 2017-10-10.
- https://www.nobelprize.org/nobel_prizes/medicine/laureates/1934/ The Nobel Prize in Physiology or Medicine 1934], Nobelprize.org, Nobel Media AB 2014. Retrieved December 2, 2015.
- Gille, D; Schmid, A (February 2015). "Vitamin B12 in meat and dairy products". Nutrition Reviews. 73 (2): 106–15. doi:10.1093/nutrit/nuu011. PMID 26024497.
- McDowell, Lee Russell (2008). Vitamins in Animal and Human Nutrition (2nd ed.). Hoboken: John Wiley & Sons. p. 525. ISBN 9780470376683. Archived from the original on 2017-09-08. CS1 maint: discouraged parameter (link)
- "Soils". Waikato University. Archived from the original on 2012-01-25. Retrieved 2012-01-16. CS1 maint: discouraged parameter (link)
- "Hedley Ralph Marston 1900–1965". Biographical Memoirs of Deceased Fellows. Australian Academy of Science. Archived from the original on 2006-12-06. Retrieved 12 May 2013.
- Greer, John P. (2014). Wintrobe's Clinical Hematology Thirteenth Edition. Philadelphia, PA: Wolters Kluwer/Lippincott Williams & Wilkins. ISBN 978-1-4511-7268-3. Unknown parameter
|name-list-format=ignored (help) Chapter 36: Megaloblastic anemias: disorders of impaired DNA synthesis by Ralph Carmel. The gold standard of clinical hematology textbooks since 1942.
- Hunt, A.; Harrington, D.; Robinson, S. (4 September 2014). "Vitamin B12 deficiency". BMJ. 349. g5226. doi:10.1136/bmj.g5226. PMID 25189324.
- Pacholok, Sally M.; Stuart, Jeffrey J. (2011). Could It Be B12?: An Epidemic of Misdiagnoses. Fresno, CA: Linden Publishing. ISBN 978-1-61035-065-5. Unknown parameter
- Hooper, M. (2012). Pernicious Anaemia: The Forgotten Disease – the causes and consequences of Vitamin B12 Deficiency. London: Hammersmith Press. ISBN 978-1-78161-004-6. Unknown parameter
- https://www.webmd.com/a-to-z-guides/vitamin-b12-deficiency-anemia-topic-overview WebMD overview
- Vitamin B12 and Folate at Lab Tests Online